MicroRNA (miR) are suggested to influence both mitochondrial function and the development of AF. Yet mitochondrial function and miR expression remain largely unexplored in human atrial tissue. This study aims to investigate mitochondrial function and miR expression in the right (RA) and left atria (LA) of patients with AF and sinus rhythm (SR). Myocardial tissue from the RA and LA appendages was investigated in 37 patients with AF (n ϭ 21) or SR (n ϭ 16) undergoing coronary artery bypass surgery and/or heart valve surgery. Mitochondrial respiration was measured in situ after tissue permeabilization by saponin. MiR expression was assessed by miR array and real-time quantitative reverse-transcription polymerase chain reaction. Maximal mitochondrial respiratory rate was increased in both RA and LA tissue of patients with AF vs. SR. Biatrial downregulation of miR-208a and upregulation of miR-106b, -144, and -451 were observed in AF vs. SR. In addition, miR-15b was upregulated in AF within RA only, were upregulated in AF within LA only. These findings suggest that mitochondrial function and miR are involved in AF pathophysiology and should be areas of focus in the exploration for potential novel therapeutic targets.
atrial fibrillation; atrium; myocardium; mitochondria; microRNA ATRIAL FIBRILLATION (AF) CONSTITUTES the most common cardiac arrhythmia in clinical practice, the incidence of which is expected to increase over the next decades (7) . Current treatment modalities of AF, such as antiarrhythmic and rate-regulating drugs have constrained effectiveness because they only influence a subset of ionic channels, and the success rate of ablation therapy is also limited in its long-term ability to prevent disturbance in myocardial electrophysiology (26) . This may be attributed to the fact that none of the currently available treatment options target the underlying pathophysiological processes of the disease (26) . Further understanding of cellular alterations in AF have been called for to ultimately improve management strategies for AF (25) . While investigations of human myocardium are sparse in general, studies of left atrial (LA) tissue are particularly limited, as the right atrial (RA) appendage is generally more readily available for investigation.
Although AF-induced atrial remodeling involves processes closely linked to mitochondrial function, mitochondria have not been a major focus in research on AF. A recent study links preoperative mitochondrial function of the RA appendage and the risk for new-onset postoperative AF after coronary artery bypass graft (CABG) surgery in patients with metabolic syndrome (17) . While mitochondria must keep up with a high demand for energy through oxidative phosphorylation, balancing its different tasks is important and focus must also remain on sustaining homeostasis of electrolytes and pH, as well as limiting production of reactive oxygen species (ROS) (9) . MicroRNA (miR) are small RNA molecules that regulate mRNA and have recently been indicated to influence both mitochondrial function (12) and cardiac arrhythmia (14, 28) .
This study aims to investigate mitochondrial function and miR expression in the RA and LA of patients with AF and sinus rhythm (SR).
peroperative ablation, tissue samples were obtained prior to ablation. St. Thomas (Martindale Pharmaceuticals, Brentwood, UK) crystalloid or blood cardioplegia was administered for myocardial protection approximately every 20 min. Heart rhythm was monitored pre-and peroperatively by electrocardiography.
Tissue samples. Tissue was obtained from the RA appendage during venous cannulation, whereas tissue from the LA appendage was obtained during CPB. One part of each sample was transferred to a preservation solution and used for mitochondrial respiratory assessment, and another was immediately snap-frozen in liquid nitrogen and kept at Ϫ80°C for miR analyses.
Mitochondrial respiration in situ. Assessment of mitochondrial respiratory rates was performed in situ as previously described and reviewed by others (11, 19) . Connective tissue was removed by fine dissection under a microscope, and the remaining myocardium transformed from dense tissue to a fine net with precise forceps, while continuously maintained at 4°C. The sample was submerged in a storage solution with an added 50 g/ml saponin for 30 min at 4°C under continuous shaking to permeabilize cell membranes while leaving mitochondrial membranes intact. Next, the sample was placed into pure storage solution and shaken for Ն10 min to remove any residue of saponin, followed by another rinse cycle of 10 min in respiration solution. The permeabilized myocardial tissue was placed into 3 ml of respiration solution inside a water-jacketed respiration cell, where a Clark-type microcathode oxygen electrode (Strathkelvin Instruments, Glasgow, UK) with a fluorinated ethylene propylene membrane was used for respiration measurement. The storage solution contained 2.77 mM CaK 2EGTA, 7.23 mM K2EGTA (100 nM free Ca 2ϩ ), 6.56 mM MgCl2 (1 mM free Mg 2ϩ ), 20 mM taurine, 0.5 mM dithiothreitol (DTT), and 20 mM imidazole 50 mM potassiummethanesulfonate (CH3KO3S), 5.7 mM Na2ATP, 15 mM phosphocreatine (pH 7.1 at 22°C). The respiration solution contained 2.77 mM CaK2EGTA, 7.23 mM K2EGTA (100 nM free Ca 2ϩ ), 1.38 mM MgCl2 (1 mM free Mg 2ϩ ), 20 mM taurine, 0.5 mM DTT, and 20 mM imidazole (pH 7.1 at 22°C), 90 mM potassium-methanesulfonate (CH3KO3S), 10 mM sodium-methanesulfonate (CH3SO3Na), 3 mM K2HPO4, 10 mM glutamate, 4 mM malate, and 2 mg/ml bovine serum albumin. Basal respiratory rate (V0) was assessed with glutamate and malate as substrates for Complex I of the electron transport chain in the absence of adenosine diphosphate (ADP), followed by the addition of a subsaturating amount of 0,1 mM ADP, registering VADP. The addition of 20 mM creatine allowed measurement of Vcreatine. Supplementation of a saturating amount of 2 mM ADP preceded assessment of the maximal respiration rate of the electron transport chain complex I through IV with glutamate and malate as substrates (Vmax). We added 10 mM succinate, supplementing complex II of the respiratory chain (Vsuccinate), after which addition of complex I inhibitor amytal (1 mM amobarbital) allowed assessment of complex II (Vamytal). Furthermore, the supplement of ascorbate (0.5 mM) and N,N,N=,N=-tetramethyl-p-phenylenediamine (TMPD, 0.5 mM) induced complex IV activity (VascorbateTMPD). At last, respiration rates were assessed with irreversible inhibition of cytochrome c oxidase (complex IV), accomplished by addition of azide (4 mM) (Vazide). Tissue samples were dried in a heat centrifuge at 60°C for 75 min before being weighed. Respiratory rates are given as micromoles O2 per minute per gram dry weight myocardial tissue (mol O2·min Ϫ1 ·g dw Ϫ1 ). The ratio of Vmax/V0, referred to as the acceptor control ratio (ACR), quantifies the degree of coupling between oxidation and phosphorylation. Mitochondrial sensitivity to ADP was estimated by VADP/Vmax. The effect of creatine on respiration is given as percent increase in respiratory rate (1RR Cr). Vamytal/Vmax estimates excess respiration of the cytochrome oxidase complex. The apparent constant of Michaelis for ADP was estimated both in the absence [ app Km (ADPϪCr) ] and in the presence of creatine [ app Km (ADPϩCr) ] (19) . miR expression. All samples with sufficient amounts of tissue underwent miR analyses: RA SR n ϭ 12, RA AF n ϭ 20, LA SR n ϭ 8, LA AF n ϭ 20. All miR analyses including RNA isolation, miR array and quantitative reverse-transcription polymerase chain reaction (qRT-PCR) were performed at Exiqon Services, Vedbaek, Denmark. Tissue samples were transported from St. Olav's Hospital, Norway, to Exiqon Services, Denmark, on dry ice transportation medium. Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA) was used to control RNA quality. Samples were labeled for miR array using Exiqon's miRCURY LNA microRNA Hi-Power Labeling Kit, Hy3/Hy5 and hybridized on the miRCURY LNA microRNA Array 6th gen (Exiqon) containing capture probes targeting all human miRs registered in miRBASE 16.0. A Tecan HS4800 hybridization station (Tecan) was used for hybridization. Array slides were scanned on the Agilent G2565BA Microarray Scanner System (Agilent Technologies), and the image analysis was carried out with the ImaGene 9 (miRCURY LNA microRNA Array Analysis Software, Exiqon). The quantified signals were background corrected and then normalized with the global Lowess (LOcally WEighted Scatterplot Smoothing) regression algorithm. The miRCURY LNA Universal RT miRNA PCR pick and mix custom panel was used for miR RT-qPCR designed to detect miR-1, -100, -106a, -106b, -10b, -125b, -133a, -133b, 138-1*, -142-5p, -144, -146a, -155, -15b, -17, -187, -18a, -18b, -191, -193a-3p, -199a-5p, -19a, -19b, -208a, -208b, -21, -23a, -25, -26a, -26b, -29b, -30a, -30b, -328, -363, -451, -486-5p, -590-5p, -600, -92a, -92b, -93. Amplification was performed with LightCycler 480 Real-Time PCR System (Roche). The amplification curves were analyzed with Roche LC software, both for determination of crossing point (Cp) and for melting curve analysis. The amplification efficiency was calculated with algorithms similar to the LinReg software. The average of five normalization assays detected in all samples was used for normalization. miR expression from RT-qPCR are presented as normalized crossing point (dCp), calculated by subtracting the Cp of the specific miR from the average Cp of normalization miRs.
Statistical analysis. Statistics were performed with SPSS 21.0 for Mac (IBM SPSS Statistics, Chicago, IL). Unpaired Student's t-test was used for between-group comparison for continuous variables. A two-tailed P value Ͻ 0.05 was considered significant. Pearson's 2 and Fisher's exact test were used for categorical data. HochbergBonferroni correction was applied to analyses of miR expression. Graphics were produced by the use of GraphPad Prism 5 (GraphPad Software, San Diego, CA).
RESULTS
Clinical data are presented in Table 1 . Patient characteristics were similar in AF vs. SR, except for an increased number of patients with mitral valve disease in patients with AF (76% in AF vs. 44% in SR). Preoperative transthoracic echocardiographic evaluation of LA diameter was documented for 25 patients (68%) (12 in SR and 13 in AF), revealing a tendency of LA dilatation (defined as LA diameter Ն41 mm) in AF, though not statistically significant (17% in SR vs. 54% in AF, P ϭ 0.10). Among patients with a history of AF, 55% were in AF on electrocardiography (ECG) immediately preoperatively (of which 10 were diagnosed with cAF and 1 with pAF).
Mitochondrial respiration. AF was associated with increased maximal mitochondrial respiration rates (V max ) in the myocardium of both RA (Fig. 1A) and LA (Fig. 1B ) compared with patients with SR.
Within RA, significantly higher mitochondrial respiration rates were observed in AF samples for V ADP (AF 4.2 Ϯ 1.8 vs. SR 2.8 Ϯ 1.4, P ϭ 0.02), V max (AF 9.8 Ϯ 3.4 vs. SR 7.1 Ϯ 2.6, P ϭ 0.01), and V succinate (AF 12.3 Ϯ 4.3 vs. SR 8.2 Ϯ 3.2, P ϭ 0.01).
Within LA, respiratory rates were significantly elevated in AF compared with SR with regards to V creatine (AF 7.7 Ϯ 3.0 vs. SR 5.1 Ϯ 2.2, P ϭ 0.02) and V max (AF 10.1 Ϯ 3.3 vs. SR 7.5 Ϯ 2.1, P ϭ 0.03).
No significant differences were observed between AF vs. SR in ACR, ADP sensitivity, creatine-induced respiration rate, excess respiration of the cytochrome oxidase complex, app K m (ADPϪCr) , or app K m (ADPϩCr) in either RA (Table 2) or LA (Table 3 ).
An analysis of subgroups pAF vs. cAF was judged inappropriate due to the number of patients included. However, a tentative examination revealed similar maximal mitochondrial respiration rates in both subgroups (RA V max : SR 7.1 Ϯ 2.6, pAF 9.6 Ϯ 3.8, cAF 9.9 Ϯ 3.2, and LA V max : SR 7.5 Ϯ 2.1, pAF 10.2 Ϯ 3.5, cAF 10.1 Ϯ 3.4).
miR. Within RA, expression of miR-106b, miR-144, miR15b, and miR-451 was significantly increased in AF compared with SR, whereas miR-208a was significantly downregulated in AF vs. SR (Fig. 2A) .
The largest number of differences in miR expression between the experimental groups was found in LA samples (Fig.  2B) ; significantly elevated expression levels were observed for miR- 106a, -106b, miR-144, miR-18a, miR-18b, miR-19a,  miR-19b, miR-23a, miR-25, miR-30a, miR-363 , miR-451, miR-486-5p, miR-590-5p and miR-93, whereas there was significantly reduced expression of miR-208a in AF vs. SR.
DISCUSSION
This is to our knowledge the first study to demonstrate that AF is associated with increased maximal mitochondrial respiratory rates of both RA and LA myocardium compared with patients with normal SR. This is interesting both because it supports the hypothesis that mitochondria play a role in AF pathophysiology and because it provides evidence that AFassociated alterations involve both atria. Most previous human studies investigating underlying mechanisms of AF have included the RA appendage only (1, 10, 16, 22) , whereas investigations including the LA appendage have mainly been re- given as means Ϯ SE in mol O2·min Ϫ1 ·g dry weight Ϫ1 (dw) of myocardial tissue. RA SR n ϭ 16, RA AF n ϭ 21, LA SR n ϭ 10, LA AF n ϭ 21. V0, basal respiration rate in the presence of glutamate and malate (substrates for complex I in the electron transport chain) without adenosine diphosphate (ADP); VADP, respiration rate with subsaturating amount of ADP; Vcreatine measurement after addition of creatine; Vmax, maximal respiration rate with saturating amount ADP and glutamate and malate as substrates; Vsuccinate, respiration rate with succinate supplementing complex II; Vamytal respiration rate while inhibiting complex I with amytal; VascorbateTMPD, following addition of ascorbate (0.5 mM) and N,N,N=,N=-tetramethyl-p-phenylenediamine (TMPD, 0.5 mM) which induces respiration in complex IV; Vazide, respiration after irreversible inhibition of complex IV by azide. Error bars Ϯ SE, *P Ͻ 0.05.
served for animal studies (1) . In accordance with our findings, biatrial remodeling has also been demonstrated in animal experimental studies of AF (1, 18) .
It can be hypothesized that the increased maximal respiration rates we observe in RA and LA tissue from AF patients may constitute part of an adaptive process due to increased atrial energy demand during AF (1, 29) . A near threefold increase in atrial oxygen consumption and coronary blood flow has been observed in AF (29) . Significant reduction of phosphocreatine levels was found in myocardium of goats in the initial phase of experimentally induced AF; however, normal levels were restored after 8 -16 wk, indicating that the increased energy demand may constitute a transient phase in the early stages of AF (1) . The in situ method of assessing mitochondrial respiration does not resolve whether the increased respiratory capacity is due to increased number or increased efficiency of mitochondria, but examination with electron microscopy after experimentally induced AF has demonstrated an increase in both number and size of mitochondria in RA as well as LA of dogs (18) . Elevated protein levels of respiratory complex I through V were found in RA tissue from patients with permanent AF (22) , further indicating an elevated energy demand in AF. Mitochondrial oxidases have been indicated as a main source of ROS in long-standing AF, and inhibition of mitochondrial complex I was shown to reduce production of ROS in RA tissue from patients with permanent AF (22) . Structural disruption of the sarcoplasmic reticulum has been demonstrated in dogs with AF, potentially contributing to disturbance of electrolyte homeostasis (18) .
We observed altered miR expression in both atria from patients with AF vs. SR. Biatrial increase of miR-106b expression was observed in AF patients in our study. Investigations of cultured myocytes from mice have demonstrated a correlation between miR-106b overexpression and destruction of mitochondrial ultrastructure through mitochondrial swelling, along with decreased mitochondrial membrane potential and increased ROS production. These findings were observed in the absence of significantly altered ATP levels (32) . We found increased expression of miR-144 and -451 in AF vs. SR of both atria. miR-144 and -451 have been linked to the prevention of cardiomyocyte death from ischemia-reperfusion through the cyclooxygenase-2 signaling pathway (31). We also observed decreased expression of the cardiospecific miR-208a in both atria from AF patients compared with SR. There are indications that miR-208a may have a central role as a regulator of the cardiac conduction system (3). A study of mice characterized by miR-208a deletion (miR208aϪ/Ϫ mice) revealed that 80% of the mice lacked P-waves preceding the QRS complexes on ECG, suggesting that MiR208aϪ/Ϫ mice suffer from AF (3). Mice characterized by overexpression of miR-208a displayed significantly prolonged PR intervals on ECG (3), indicating that balanced miR-208a expression is necessary for normal heart rhythm.
Significant upregulation of miR-15b was observed in patients with AF vs. SR in RA tissue. A recent study demonstrated that overexpression of miR-15b is associated with disturbance of mitochondrial integrity in murine cardiomyocytes, and conversely supplementing anti-miR-15b restored cardiac function in a mouse model of heart failure (23). Investigations of ventricular cells from neonatal rats have also demonstrated that elevated miR-15b expression is associated with disturbance of mitochondrial integrity and reduced ATPlevels without affecting myocyte viability (20) .
In addition to the alterations in miR expression that were observed in both atria, miR-106a, -18a, -18b, -19a, -19b, -23a, -25, -30a, -363, -486-5p, -590-5p and -93 were upregulated in AF patients vs. SR in LA tissue only. miR-106a has been linked to regulation of macrophage inflammatory responses (33) . miR-18a, miR-19a, and miR-19b constitute part of the miR-17-92 cluster. It was recently demonstrated that dysregulation of miR-17-92 induce dilated, hypertrophic cardiomyopathy, arrhythmogenesis, and premature mortality in mice (5) . miR-23a has been shown to mediate cardiac hypertrophy, and mice with increased expression of miR-23a are more susceptible to undergoing hypertrophy upon insults such as pressure overload compared with mice with reduced miR-23a expression (27) . miR-25 has been linked to decreased calcium uptake through the mitochondrial calcium uniporter, which in turn appear to enhance cellular resistance against apoptosis (15) . miR-363 is part of the miR-25 family and is associated with the same effects on calcium homeostasis as miR-25 (15) . There are indications that miR-30a is involved in angiotensin II-induced cardiac remodeling, as increased miR-30a expression attenuates, and miR-30a inhibition promotes angiotensin II-induced hypertrophy in cardiomyocytes (21) . A murine model of hindlimb ischemia demonstrated that miR-93 has a potent ability to promote reperfusion after ischemia, as well as to enhance cell survival after hypoxia and serum starvation in endothelial and skeletal muscle cells (8) . Additionally, in vitro studies have revealed proangiogenic features of miR-93, and increased capillary density was observed after hindlimb ischemia in mice overexpressing miR-93 (8) . One may hypothesize that these features would represent an advantage in rapidly contracting atria during AF. It has recently been demonstrated that miR-18b may inhibit the process of transforming growth factor-␤-induced differentiation into smooth muscle cells (13) , and miR-486-5p has been linked to accumulation of superoxide anion, induction of DNA damage, and reduced cell proliferation, contributing to a senescent phenotype in human fibroblasts (6) . While downregulation of miR-590-5p increased atrial collagen production and fibrosis, upregulation of miR-590-5p decreased the fibrotic response in a canine model of nicotineinduced AF (24) . miR expression profiles have recently been investigated in the RA appendages of patients with mitral stenosis with and without AF (30) and in RA and LA appendages from patients with AF and valvular heart disease (4). The described miR expression profiles diverge between the two studies. miR-208a was downregulated and miR-18b was upregulated in RA of patients with AF relative to that of healthy controls, in accordance with our observations (30) . However, RA miR-18a and -19b were downregulated in AF as opposed to in our study (30) . None of the miRs assessed in our study were investigated with PCR in the study of patients with valvular heart disease and AF, precluding detailed comparison (4) . The inconsistency of results may reflect both that the current understanding of miR expression in patients with AF is at a preliminary stage and that the population of patients with AF is heterogeneous.
Study implications and limitations.
Although we intended to obtain comparable patient groups, there is a possibility of interference between AF-induced alterations vs. alterations due to comorbidities. Investigations of structural and functional alterations in myocardial tissue of "lone" AF in human subjects are sparse; however, studies of goats and dogs have demonstrated AF-specific alterations in the absence of significant comorbidity (2, 18) .
The atrial appendage was used for investigation because it constitutes the most accessible and nontraumatic location for sampling human myocardial tissue. Investigations of structural changes in a goat model of experimental AF indicates that alterations of the atrial appendages also applies to other parts of the atrial myocardium (2), but this has not been verified in human myocardium.
While assessment of mitochondrial respiratory capacity in situ has several advantages (11), the method does not identify whether the difference in mitochondrial respiratory capacity is due to qualitative or quantitative changes of the mitochondria. An investigation allowing quantification of the number of mitochondria in the atrial tissue would have provided valuable additional information but was precluded in the current study due to limited amount of tissue.
Direct measurement of ROS production as well as investigations of mitochondrial morphology would have added valuable information but was precluded due to limited tissue availability.
Existing data on the roles of miRs in the human heart and AF are sparse and mainly associative in nature. Further research is needed to establish causal relations. 
